+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Attention Deficit Hyperactivity Market by Drug Type (Stimulant and Non-stimulant), Demographic (Adult and Children), Distribution Channel (Retail Pharmacy and Hospital Pharmacy), and Geography - Global Forecast up to 2026

  • PDF Icon

    Report

  • 120 Pages
  • July 2021
  • Region: Global
  • IHR Insights
  • ID: 5446396
10% Free customization
Description Jump to:
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Attention Deficit Hyperactivity Market is projected to grow at the rate of 8.4% CAGR by 2026. Attention deficit hyperactivity disorder is considered as a mental illness previously known as attention deficit disorder. It generally affects children and also adults in few cases. Attention deficit hyperactivity disorder is a condition where the patient has difficulty sitting still, performing or concentrating on tasks, and paying attention. The patient with this disorder behaves without thinking. This disease can be diagnosed between the age of 6 and 12 years. The key fueling factor of the attention deficit hyperactivity market is the growing number of early births of babies. Research by the University of Maryland Medical Center (UMMC) indicated that 20% of preterm babies have this disorder in the present day. The rising trend of consuming toxins such as alcohol, cigarette, and drugs in pregnant women would result in children with attention deficit hyperactivity disorder. The alternative therapies such as vitamins, special diets, minerals, and herbs may hinder the attention deficit hyperactivity disorder market during growth over the forecast period.

The Attention Deficit Hyperactivity Market is has been segmented on the basis of:


Attention Deficit Hyperactivity Market based on Drug Type


  • Stimulant
  • Non-stimulant

Attention Deficit Hyperactivity Market based on Demographic


  • Adult (Aged 18 and above)
  • Children

Attention Deficit Hyperactivity Market based on Distribution Channel


  • Retail Pharmacy
  • Hospital Pharmacy

Attention Deficit Hyperactivity Market based on Geography


  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The attention deficit hyperactivity market is bifurcated into stimulant and non-stimulant based on drug type. The stimulant drug type has a significant share in the attention deficit hyperactivity market. The major share is due to the huge demand for these drugs due to their effectiveness in treating attention deficit hyperactivity disorder symptoms. Ongoing clinical trials and government provision for the use of stimulants to treat mental health disorders are other factors driving the segment’s growth.

As per the demography, the attention deficit hyperactivity market is divided into adults and children. The adult segment is accounted for a substantial share in the market. This is due to the huge patient population, and it is considered that most of the adult population in the United States are affected by attention deficit hyperactivity.

According to the distribution channel, the channels are categorized into a retail pharmacy and a hospital pharmacy. Compared to hospital pharmacies, the retail pharmacy holds the maximum share in the market due to the rising number of prescriptions, increased inpatient care initiatives by retail pharmacies, and most patients prefer purchasing drugs from retail pharmacies.

In terms of geographic segment, the North American region holds a major position in the market share. The factors such as the presence of key players in the region and the rising number of collaborations are increasing market penetration. Moreover, the increase in product launches also enhances the market's growth in the region.

In addition, the increasing awareness among people worldwide about maintaining mental health is one of the key factors driving the market growth. The changes in the living style and value systems of people have affected the quality of birth. Additionally, the increasing use of preservatives and additives in children’s diets raises the number of attention deficit hyperactivity disorder cases among the age group of 4-17 years. Therefore, this is fueling the growth of the global market.

This report includes the key players of the attention deficit hyperactivity market: Eli Lilly & Company, Supernus Pharmaceuticals, Inc., Johnson & Johnson Services Inc, Hisamitsu Pharmaceutical Co., Inc Lupin Limited, NEOS Therapeutics Inc., Mallinckrodt Pharmaceuticals, and Impax Laboratories, LLC.

Henceforth, poor nutrition, infections, smoking, drinking, and substance abuse during pregnancy are the common reasons for the cause of attention deficit hyperactivity, where various therapeutics and drugs have a prominent role in the treatment. Moreover, this disorder is considered a social stigma since the emphasis on ADHD treatment has increased.
  • To provide an inclusive analysis on the attention deficit hyperactivity market by drug type, by age group, by distribution channel, and by region
  • To cater complete information on factors influencing market growth such as drivers, restraints, opportunities, and industry-specific restraints
  • To estimate the market size in key regions, which include North America, Europe, Asia Pacific, and the rest of the world
  • To register and evaluate competitive landscape mapping-product launches, technological advancements, mergers, and expansions

Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Drug Type: Market Size & Analysis
5.1. Overview
5.2. Stimulant
5.3. Non-stimulant
6. Demographic: Market Size & Analysis
6.1. Overview
6.2. Adult (Aged 18 and above)
6.3. Children
7. Distribution Channel: Market Size & Analysis
7.1. Overview
7.2. Retail Pharmacy
7.3. Hospital Pharmacy
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. Eli Lilly & Company
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. Johnson & Johnson Services Inc
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Lupin Limited
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Mallinckrodt Pharmaceuticals
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. NEOS Therapeutics Inc.
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Hisamitsu Pharmaceutical Co., Inc.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Impax Laboratories, LLC
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Supernus Pharmaceuticals, Inc.
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. GlaxoSmithKline PLC
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Purdue Pharma L.P
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
List of Tables
Table 1. Global Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 2. Global Attention Deficit Hyperactivity Market Value for Stimulant, by Geography, 2020-2026 (USD Billion)
Table 3. Global Attention Deficit Hyperactivity Market Value for Non-Stimulant, by Geography, 2020-2026 (USD Billion)
Table 4. Global Attention Deficit Hyperactivity Market Value, by Demographic, by Geography, 2020-2026 (USD Billion)
Table 5. Global Attention Deficit Hyperactivity Market Value for Adult, by Geography, 2020-2026 (USD Billion)
Table 6. Global Attention Deficit Hyperactivity Market Value for Children, by Geography, 2020-2026 (USD Billion)
Table 7. Global Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 8. Global Attention Deficit Hyperactivity Market Value for Retail Pharmacy, by Geography, 2020-2026 (USD Billion)
Table 9. Global Attention Deficit Hyperactivity Market Value for Hospital Pharmacy, by Geography, 2020-2026 (USD Billion)
Table 10. North America Attention Deficit Hyperactivity Market Value, by Country, 2020-2026 (USD Billion)
Table 11. North America Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 12. North America Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 13. North America Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 14. U.S Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 15. U.S Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 16. U.S Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 17. Canada Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 18. Canada Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 19. Canada Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 20. Europe Attention Deficit Hyperactivity Market Value, by Country, 2020-2026 (USD Billion)
Table 21. Europe Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 22. Europe Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 23. Europe Attention Deficit Hyperactivity Market Value, Distribution Channel, 2020-2026 (USD Billion)
Table 24. Germany Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 25. Germany Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 26. Germany Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 27. U.K Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 28. U.K Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 29. U.K Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 30. France Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 31. France Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 32. France Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 33. Italy Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 34. Italy Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 35. Italy Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 36. Spain Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 37. Spain Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 38. Spain Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 39. Roe Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 40. Roe Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 41. Roe Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 42. Asia Pacific Attention Deficit Hyperactivity Market Value, by Country, 2020-2026 (USD Billion)
Table 43. Asia Pacific Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 44. Asia Pacific Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 45. Asia Pacific Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 46. China Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 47. China Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 48. China Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 49. India Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 50. India Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 51. India Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 52. Japan Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 53. Japan Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 54. Japan Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 55. Rest of APAC Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 56. Rest of APAC Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 57. Rest of APAC Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 58. Rest of World Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 59. Rest of World Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Table 60. Rest of World Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Table 61. Eli Lilly & Company: Financials
Table 62. Eli Lilly & Company: Products & Services
Table 63. Eli Lilly & Company: Recent Developments
Table 64. Johnson & Johnson Services Inc: Financials
Table 65. Johnson & Johnson Services Inc: Products & Services
Table 66. Johnson & Johnson Services Inc: Recent Developments
Table 67. Lupin Limited: Financials
Table 68. Lupin Limited: Products & Services
Table 69. Lupin Limited: Recent Developments
Table 70. Mallinckrodt Pharmaceuticals: Financials
Table 71. Mallinckrodt Pharmaceuticals: Products & Services
Table 72. Mallinckrodt Pharmaceuticals: Recent Developments
Table 73. Neos Therapeutics Inc.: Financials
Table 74. Neos Therapeutics Inc.: Products & Services
Table 75. Neos Therapeutics Inc.: Recent Developments
Table 76. Hisamitsu Pharmaceutical Co., Inc: Financials
Table 77. Hisamitsu Pharmaceutical Co., Inc: Products & Services
Table 78. Hisamitsu Pharmaceutical Co., Inc: Recent Developments
Table 79. Impax Laboratories, Llc: Financials
Table 80. Impax Laboratories, Llc: Products & Services
Table 81. Impax Laboratories, Llc: Recent Developments
Table 82. Supernus Pharmaceuticals, Inc: Financials
Table 83. Supernus Pharmaceuticals, Inc: Products & Services
Table 84. Supernus Pharmaceuticals, Inc: Recent Developments
Table 85. Glaxosmithkline Plc: Financials
Table 86. Glaxosmithkline Plc: Products & Services
Table 87. Glaxosmithkline Plc: Recent Developments
Table 88. Purdue Pharma L.P: Financials
Table 89. Purdue Pharma L.P: Products & Services
Table 90. Purdue Pharma L.P: Recent Developments
List of Figures
Chart. 1. Global Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 2. Global Attention Deficit Hyperactivity Market Value for Stimulant, by Geography, 2020-2026 (USD Billion)
Chart 3. Global Attention Deficit Hyperactivity Market Value for Non-Stimulant, by Geography, 2020-2026 (USD Billion)
Chart 4. Global Attention Deficit Hyperactivity Market Value, by Demographic, by Geography, 2020-2026 (USD Billion)
Chart 5. Global Attention Deficit Hyperactivity Market Value for Adult, by Geography, 2020-2026 (USD Billion)
Chart 6. Global Attention Deficit Hyperactivity Market Value for Children, by Geography, 2020-2026 (USD Billion)
Chart 7. Global Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 8. Global Attention Deficit Hyperactivity Market Value for Retail Pharmacy, by Geography, 2020-2026 (USD Billion)
Chart 9. Global Attention Deficit Hyperactivity Market Value for Hospital Pharmacy, by Geography, 2020-2026 (USD Billion)
Chart 10. North America Attention Deficit Hyperactivity Market Value, by Country, 2020-2026 (USD Billion)
Chart 11. North America Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 12. North America Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 13. North America Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 14. U.S Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 15. U.S Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 16. U.S Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 17. Canada Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 18. Canada Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 19. Canada Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 20. Europe Attention Deficit Hyperactivity Market Value, by Country, 2020-2026 (USD Billion)
Chart 21. Europe Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 22. Europe Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 23. Europe Attention Deficit Hyperactivity Market Value, Distribution Channel, 2020-2026 (USD Billion)
Chart 24. Germany Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 25. Germany Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 26. Germany Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 27. U.K Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 28. U.K Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 29. U.K Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 30. France Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 31. France Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 32. France Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 33. Italy Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 34. Italy Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 35. Italy Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 36. Spain Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 37. Spain Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 38. Spain Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 39. RoE Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 40. RoE Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 41. RoE Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 42. Asia Pacific Attention Deficit Hyperactivity Market Value, by Country, 2020-2026 (USD Billion)
Chart 43. Asia Pacific Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 44. Asia Pacific Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 45. Asia Pacific Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 46. China Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 47. China Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 48. China Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 49. India Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 50. India Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 51. India Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 52. Japan Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 53. Japan Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 54. Japan Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 55. Rest of APAC Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 56. Rest of APAC Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 57. Rest of APAC Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)
Chart 58. Rest of World Attention Deficit Hyperactivity Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 59. Rest of World Attention Deficit Hyperactivity Market Value, by Demographic, 2020-2026 (USD Billion)
Chart 60. Rest of World Attention Deficit Hyperactivity Market Value, by Distribution Channel, 2020-2026 (USD Billion)

Companies Mentioned

  • Eli Lilly & Company
  • Supernus Pharmaceuticals Inc.
  • Johnson & Johnson Services Inc
  • Hisamitsu Pharmaceutical Co. Inc Lupin Limited
  • NEOS Therapeutics Inc.
  • Mallinckrodt Pharmaceuticals
  • Impax Laboratories LLC

Related Topics

Related Reports

Central Nervous System (CNS) Stimulant Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Central Nervous System (CNS) Stimulant Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 112 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder - Pipeline Insight, 2024 - Product Image

Attention Deficit Hyperactivity Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • 80 Pages
  • Global
From
Learning Disabilities Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Learning Disabilities Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 178 Pages
  • Global
From
Muscarinic Acetylcholine Receptor Global Market Report 2024 - Product Image

Muscarinic Acetylcholine Receptor Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Tourette Syndrome Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Tourette Syndrome Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 113 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.